New research was presented from Cardinal Health Specialty Solutions in its third edition of Oncology Insights, a research-based report. The report summarizes the views of over 160 U.S. oncologists on the potential of precision medicine to transform cancer treatment.
Some of the key findings in the report include:
Request a copy of the Oncology Insights report at www.cardinalhealth.com/oncologyinsights.
Fierce Females in the Life Science Space
March 29th 2024In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.
FDA Approves Stelara Biosimilar Selarsdi to Treat Psoriasis, Psoriatic Arthritis
April 17th 2024Alvotech’s and Teva's Selarsdi (ustekinumab-aekn), the second FDA-approved biosimilar to Stelara, is indicated to treat patients aged 6 years and above with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy and for patients aged 6 years and above with active psoriatic arthritis.